Associated Papers
Long-term prognosis of 35 patients with methionine adenosyltransferase deficiency based on newborn screening in China.
Tong F et al.
Frontiers in Cell and Developmental Biology, 2022
36704196 (PubMed )
Supplement: DataSheet1.PDF
Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations.
Nashabat M et al.
Therapeutics and Clinical Risk Management, 2018
Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes.
Chien YH et al.
Orphanet Journal of Rare Diseases, 2015
Spectrum of mutations associated with methionine adenosyltransferase I/III deficiency among individuals identified during newborn screening in Japan.
Nagao M et al.
Molecular Genetics and Metabolism, 2013
S-adenosylmethionine treatment in methionine adenosyltransferase deficiency, a case report.
Furujo M et al.
Molecular Genetics and Metabolism, 2012
Select a paper to view details